These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2829380)

  • 41. Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells.
    Lu H; Mirshahi M; Krief P; Soria C; Soria J; Mishal Z; Bertrand O; Perrot JY; Li H; Picot C
    Biochem Biophys Res Commun; 1988 Aug; 155(1):418-22. PubMed ID: 2843185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between leukocytes and serum plasminogen: an essential mechanism in peripheral blood fibrinolytic activity.
    Ghezzo F; Savoca P; Vallero P; Bellone G
    Am J Hematol; 1986 Jul; 22(3):233-9. PubMed ID: 3521263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmin binding to the plasminogen receptor enhances catalytic efficiency and activates the receptor for subsequent ligand binding.
    Gonzalez-Gronow M; Stack S; Pizzo SV
    Arch Biochem Biophys; 1991 May; 286(2):625-8. PubMed ID: 1654795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further characterization of the cellular plasminogen binding site: evidence that plasminogen 2 and lipoprotein a compete for the same site.
    Gonzalez-Gronow M; Edelberg JM; Pizzo SV
    Biochemistry; 1989 Mar; 28(6):2374-7. PubMed ID: 2543441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding and activation of plasminogen on the platelet surface.
    Miles LA; Plow EF
    J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.
    Murciano JC; Higazi AA; Cines DB; Muzykantov VR
    J Control Release; 2009 Nov; 139(3):190-6. PubMed ID: 19616049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion.
    Ellis V; Pyke C; Eriksen J; Solberg H; Danø K
    Ann N Y Acad Sci; 1992 Dec; 667():13-31. PubMed ID: 1339241
    [No Abstract]   [Full Text] [Related]  

  • 48. Receptors for human plasminogen on the biological response modifier OK-432.
    Ullberg M; Tewodros W; Kronvall G
    J Biol Response Mod; 1990 Dec; 9(6):592-6. PubMed ID: 1963635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor.
    Miles LA; Dahlberg CM; Plescia J; Felez J; Kato K; Plow EF
    Biochemistry; 1991 Feb; 30(6):1682-91. PubMed ID: 1847072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of plasminogen receptor expression on monocytoid cells by beta1-integrin-dependent cellular adherence to extracellular matrix proteins.
    Kim SO; Plow EF; Miles LA
    J Biol Chem; 1996 Sep; 271(39):23761-7. PubMed ID: 8798602
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of receptor bound urokinase-type plasminogen activator on human monocytes by non-steroidal antiinflammatory drugs.
    Kirchheimer JC
    Scand J Rheumatol; 1993; 22(2):53-7. PubMed ID: 8386851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immobilisation of monocytes to a solid support: a model for the study of ligand-binding interactions and plasminogen activation at the cell surface.
    Soulat T; Dominguez M; Martin I; Anglés-Cano E
    Thromb Res; 1999 Dec; 96(6):473-80. PubMed ID: 10632471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of urokinase plasminogen activator receptor on monocytes and granulocytes is modulated by cardiac surgery.
    Krejsek J; Kolackova M; Kunes P; Jankovicova K; Mandak J; Andrys C
    Perfusion; 2011 Mar; 26(2):115-21. PubMed ID: 21078770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The binding of diiodosalicylate and flufenamate to the plasma antiactivator: analysis of chemical fibrinolysis.
    Nanninga LB
    Thromb Haemost; 1979 Apr; 41(2):357-64. PubMed ID: 572998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endotoxin receptor site. I. Binding of endotoxin to platelets.
    Washida S
    Acta Med Okayama; 1978 Jun; 32(2):159-67. PubMed ID: 150201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urokinase receptors in human monocytes.
    Nykjaer A; Petersen CM; Christensen EI; Davidsen O; Gliemann J
    Biochim Biophys Acta; 1990 May; 1052(3):399-407. PubMed ID: 2162216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon receptors: are they present on human blood cells?
    van Hinsbergh VW; Nooijen WJ; Kempen HJ
    Horm Metab Res; 1982 Feb; 14(2):65-8. PubMed ID: 6279478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration].
    Arefieva TI; Krasnikova TL; Parfenova EV; Alekseeva IA
    Biull Eksp Biol Med; 1998 Aug; 126(8):147-9. PubMed ID: 9777222
    [No Abstract]   [Full Text] [Related]  

  • 59. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
    Vassalli JD; Baccino D; Belin D
    J Cell Biol; 1985 Jan; 100(1):86-92. PubMed ID: 3880760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells.
    Nykjaer A; Petersen CM; Møller B; Andreasen PA; Gliemann J
    FEBS Lett; 1992 Mar; 300(1):13-7. PubMed ID: 1312484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.